Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: A follow-up study based on 138 cases from a diagnostic variability study
- 1 April 2001
- journal article
- Published by Elsevier in Human Pathology
- Vol. 32 (4), 379-388
- https://doi.org/10.1053/hupa.2001.23511
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Clonal Expansion and Loss of Heterozygosity at Chromosomes 9p and 17p in Premalignant Esophageal (Barrett's) TissueJNCI Journal of the National Cancer Institute, 1999
- Evolution of neoplastic cell lineages in Barrett oesophagusNature Genetics, 1999
- Barrett Esophagus With Dysplasia:Flow Cytometric DNA Analysis of Routine, Paraffin-Embedded Mucosal BiopsiesAmerican Journal of Clinical Pathology, 1996
- 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus.Proceedings of the National Academy of Sciences, 1996
- Molecular analysis of the TP53 gene in Barrett's adenocarcinomaHuman Mutation, 1996
- Expansion of the Ki-67 proliferative compartment correlates with degree of Dysplasia in Barrett's esophagusCancer, 1995
- p53 protein expression in Barrett's adenocarcinoma: a frequent event with no prognostic significanceHistopathology, 1994
- Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancerThe American Journal of Surgery, 1994
- Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations.Journal of Clinical Pathology, 1994
- Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma.Proceedings of the National Academy of Sciences, 1993